About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Flu Vaccine Boosts Sleep Disorder Risk Among Teens and Children

by Thilaka Ravi on February 27, 2013 at 7:18 PM
Flu Vaccine Boosts Sleep Disorder Risk Among Teens and Children

A vaccine used to prevent pandemic flu boosts the risk of sleep disorder among teens and children, doctors said on Tuesday after a study in England strengthened evidence for the risk from Scandinavia.

Using the Pandemrix vaccine increased the risk of narcolepsy among people aged four to 18 by a factor of 14 compared to those who did not get the jab, they said.

Advertisement

The risk in absolute terms was between one in 52,000 people and one in 57,000, but this figure may be an over-estimate, according to the study published by the British Medical Journal (BMJ).

Narcolepsy is a chronic disorder of the nervous system that causes excessive drowsiness, often causing people to fall asleep uncontrollably.

It normally occurs among 25-50 of every 100,000 people, although figures are sketchy, the study said.
Advertisement

Pandemrix was the main vaccine used to fight the 2009-2010 outbreak of H1N1 "swine" flu, a much-feared pandemic involving a novel strain influenza virus.

The bug turned out to be as dangerous as normal "seasonal" flu, a discovery prompting some accusations that health watchdogs had over-reacted.

Last September, the European Centre for Disease Prevention and Control (ECDC) said that, on the basis of evidence from sleep centres in Finland and Sweden, vaccination for H1N1 among teenagers and children had led to a narcolepsy risk of one in 20,000.

The new research conducted in England suggests that data from the two Scandinavian countries were not a freak result, the study said.

Pandemrix uses an adjuvant, or booster, called AS03, which aims to strengthen the immune response to the H1N1 virus.

As H1N1 has largely run its course, further need of the AS03 adjuvant to fight this strain "seems unlikely," the new study said. An alternative vaccine, Celvepan, exists.

But the findings raise questions as to whether AS03 vaccines should be used against other flu strains, such as H5 and H9 types, it added.

Asked to comment on the study, John McCauley at Britain's National Institute for Medical Research said the increased risk in narcolepsy "is possibly a one-off" as vaccines today had a different formula from Pandemrix.

Even so, "surveillance needs to be continued," he said.

The research did not compare the risk of narcolepsy with the risk from contracting H1N1 if unvaccinated.

More than a fifth of the world's population was infected with the H1N1 virus in the 2009-2010 pandemic, according to estimates published last month.

Children aged five to 19 had the highest rates of infection, accounting for 47 percent of the total. Older people aged 65 and over accounted for 11 percent.

By the time the pandemic was officially over in August 2010, countries had notified the UN's World Health Organisation (WHO) of less than a million infections and around 18,500 deaths, but this has always been known to be a fraction of the toll.

Source: AFP
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Drug News

WHO Approves R21/Matrix-M, the World's Second Malaria Vaccine
R21/Matrix-M, the world's second malaria vaccine is readily deployable, and cost-effective making it prepared for distribution in areas where it is most essential.
New Inverse Vaccine Sparks Hope in Diabetes, Arthritis, and Crohn's Disease
The reverse vaccine uses the liver's natural "non-target" signals to prevent autoimmune responses against naturally decaying cells.
Projected Growth: Psychedelic Drug Market Anticipated to Hit $7.2 Billion by 2029
The psychedelic market set for remarkable growth, projected to hit $7.2B by 2029 with a strong 55% CAGR.
Promising ALS Drug Candidate Extends Lifespan
The study explores whether CDNF could influence the progression of ALS in rodent models and to elucidate the mechanism through which it operates.
Amoxicillin-Calvulanate Vs Amoxicillin Preference in Child Sinusitis Treatment
Amoxicillin-clavulanate use in acute sinusitis patients is associated with a higher incidence of adverse events.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
MediBotMediBot
Greetings! How can I assist you?MediBot
×

Flu Vaccine Boosts Sleep Disorder Risk Among Teens and Children Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests